Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by BPGbio

BPGbio Presents Phase 2 Glioblastoma Data on BPM31510 at ESMO 2025
From BPGbio
Via GlobeNewswire
BPGbio Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani as Executive in Residence
From BPGbio
Via GlobeNewswire
BPGbio Appoints Veteran Clinical and Commercial Leader Dr. Brian Berman as Interim Chief Medical Officer
From BPGbio
Via GlobeNewswire
BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025
From BPGbio
Via GlobeNewswire
BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer
From BPGbio
Via GlobeNewswire
BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM)
From BPGbio
Via GlobeNewswire
BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025
From BPGbio
Via GlobeNewswire
BPGbio Announces Presentation of Preliminary Clinical Data of Investigational BPM31510 for Primary CoQ10 Deficiency
From BPGbio
Via GlobeNewswire
BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
From BPGbio
Via GlobeNewswire
BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference
From BPGbio
Via GlobeNewswire
BPGbio Presents New Research on Tumor Metabolism, Immunotherapy, and Diagnostics at AACR Annual Meeting 2025
From BPGbio
Via GlobeNewswire
BPGbio's Lipidomics Expertise Powers Groundbreaking Discovery of Lipid-Rich Cartilage Published in Science
From BPGbio
Via Business Wire
BPGbio Announces Publication in Scientific Reports on Validation of Novel Diagnostic Biomarker Panel for Parkinson’s Disease
From BPGbio
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.